Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma

Anstee, 2013, Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis, Nat Rev Gastroenterol Hepatol, 10, 330, 10.1038/nrgastro.2013.41 Ratziu, 2010, A position statement on NAFLD/NASH based on the EASL 2009 special conference, J Hepatol, 53, 372, 10.1016/j.jhep.2010.04.008 Anstee, 2011, How big a problem is non-alcoholic fatty liver disease?, BMJ, 343, d3897, 10.1136/bmj.d3897 El-Serag, 2007, Hepatocellular carcinoma: epidemiology and molecular carcinogenesis, Gastroenterology, 132, 2557, 10.1053/j.gastro.2007.04.061 Nordenstedt, 2010, The changing pattern of epidemiology in hepatocellular carcinoma, Dig Liver Dis, 42, S206, 10.1016/S1590-8658(10)60507-5 EASL-EORTC clinical practice guidelines, 2012, Management of hepatocellular carcinoma, J Hepatol, 56, 908, 10.1016/j.jhep.2011.12.001 Dyson, 2014, Hepatocellular Cancer – the impact of obesity, type 2 diabetes and a multidisciplinary team, J Hepatol, 60, 110, 10.1016/j.jhep.2013.08.011 Parkin, 2006, The global health burden of infection-associated cancers in the year 2002, Int J Cancer, 118, 3030, 10.1002/ijc.21731 Baffy, 2012, Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace, J Hepatol, 56, 1384, 10.1016/j.jhep.2011.10.027 Starley, 2010, Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection, Hepatology, 51, 1820, 10.1002/hep.23594 Guzman, 2008, Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?, Arch Pathol Lab Med, 132, 1761, 10.5858/132.11.1761 Hashimoto, 2009, Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis, J Gastroenterol, 44, 89, 10.1007/s00535-008-2262-x Ascha, 2010, The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis, Hepatology, 51, 1972, 10.1002/hep.23527 Sanyal, 2010, Population-based risk factors and resource utilization for HCC: US perspective, Curr Med Res Opin, 26, 2183, 10.1185/03007995.2010.506375 Anstee, 2013, The genetics of NAFLD, Nat Rev Gastroenterol Hepatol, 10, 645, 10.1038/nrgastro.2013.182 Valenti, 2013, PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease, Dig Liver Dis, 45, 619, 10.1016/j.dld.2012.12.006 Romeo, 2008, Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease, Nat Genet, 40, 1461, 10.1038/ng.257 Valenti, 2010, Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease, Hepatology, 51, 1209, 10.1002/hep.23622 Guyot, 2013, PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis, J Hepatol, 58, 312, 10.1016/j.jhep.2012.09.036 Nischalke, 2011, The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis, PLoS One, 6, e27087, 10.1371/journal.pone.0027087 Trepo, 2012, PNPLA3 (rs738409 C >G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis, Hepatology, 55, 1307, 10.1002/hep.25518 Trepo, 2014, Association between the PNPLA3 (rs738409 C >G) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data, Hepatology, 10.1002/hep.26767 Valenti, 2011, Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C, Hepatology, 53, 791, 10.1002/hep.24123 Falleti, 2011, PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence, Liver Int, 31, 1137, 10.1111/j.1478-3231.2011.02534.x Burza, 2012, PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals, Dig Liver Dis, 44, 1037, 10.1016/j.dld.2012.05.006 Hassan, 2013, Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: Risk and prognosis prediction, Mol Carcinog, 52(Suppl. 1), E139, 10.1002/mc.22057 Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701 Edmondson, 1954, Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies, Cancer, 7, 462, 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E Daly, 1996, Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotype, Pharmacogenetics, 6, 319, 10.1097/00008571-199608000-00005 Purcell, 2007, PLINK: a tool set for whole-genome association and population-based linkage analyses, Am J Hum Genet, 81, 559, 10.1086/519795 Sookoian, 2009, A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity, J Lipid Res, 50, 2111, 10.1194/jlr.P900013-JLR200 Rotman, 2010, The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease, Hepatology, 52, 894, 10.1002/hep.23759 International HapMap Consortium, 2003, The international HapMap project, Nature, 426, 789, 10.1038/nature02168 El-Serag, 2004, Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma, Gastroenterology, 126, 460, 10.1053/j.gastro.2003.10.065 Burza, 2014, PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis, Liver Int, 34, 514, 10.1111/liv.12310 Romeo, 2010, Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein, Curr Opin Lipidol, 21, 247, 10.1097/MOL.0b013e328338ca61 Zimmermann, 2004, Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase, Science, 306, 1383, 10.1126/science.1100747 Al-Serri, 2012, The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies, J Hepatol, 56, 448, 10.1016/j.jhep.2011.05.029 Michelotti, 2013, NAFLD, NASH and liver cancer, Nat Rev Gastroenterol Hepatol, 10, 656, 10.1038/nrgastro.2013.183 Lade, 2014, Contributions of metabolic dysregulation and inflammation to non-alcoholic steatohepatitis, hepatic fibrosis, and cancer current reviews, Oncology, 26, 100 Sookoian, 2014, PNPLA3, the history of an orphan gene of the potato tuber PROTEIN family that found an organ: the Liver, Hepatology, 10.1002/hep.26895 Sarasin, 1996, Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis, Am J Med, 101, 422, 10.1016/S0002-9343(96)00197-0 Trevisani, 2007, Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?, Am J Gastroenterol, 102, 2448, 10.1111/j.1572-0241.2007.01395.x Manolio, 2013, Bringing genome-wide association findings into clinical use, Nat Rev Genet, 14, 549, 10.1038/nrg3523